Effects of Dipeptidyl Peptidase-4 Inhibition With Saxagliptin on Fasting and Postprandial Triglyceride Concentrations

NCT01527747 Phase 4 SUSPENDED

The purpose of this study is to test the effects of saxagliptin, a treatment for diabetes, on fasting and post-meal blood triglyceride (blood fat) levels.

Details

Lead sponsor	Oregon Health and Science University
Phase	Phase 4
Status	SUSPENDED
Enrolment	15
Start date	2012-01
Completion	2024-12

Conditions

• Type 2 Diabetes
• Hypertriglyceridemia

Interventions

• Saxagliptin

Primary outcomes

• Change in fasting and postprandial triglyceride concentrations — baseline, 6 weeks
  Comparison of 6 weeks of placebo vs 6 weeks of saxagliptin

Countries

United States